Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4)

Next Previous
Trial Profile

Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4)

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 24 Jul 2025 Status changed from recruiting to active, no longer recruiting.
  • 20 Dec 2023 According to a Meilleur Technologies Media Release, PharmaLogic will manufacture [F18]NAV4694 for use in clinical trials at select United States-based radiopharmacies.
  • 20 Oct 2023 According to a Meilleur Technologies Media Release, the company announced a research collaboration agreement with the Alzheimers Disease Neuroimaging Initiative 4, ADNI4, on the use of Meilleurs [F-18]NAV-4694, an investigational imaging agent, in Positron Emission Tomography (PET) scans to assess the status amyloid plaque in the brain.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top